AnandRathi

Syncom Formulations (India) Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
17.35
+0.32 (+1.88%)

Syncom Formulations (India) Ltd (Syncom Formul.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹1,631 crore.

Syncom Formulations (India) Ltd Overview

Market cap₹1,631 Crs
Volume7,82,351
Prev. Close₹17.03
Year range₹10.21 - ₹18.69
Total Value₹1,35,73,789.85
ISININE312C01025

Syncom Formulations (India) Ltd Fundamental Analysis

ROCE(TTM)24.51%
P/E Ratio (TTM)19.28
P/B Ratio3.96
Debt to Equity0.00
ROE18.43%
EPS (TTM)0.90
Dividend Yield0.00%
Book Value4.39
Profit Margin17.15%
Operating Margin16.27%

Syncom Formulations (India) Ltd Historical Performance

1 Month Return31.54%
6 Month Return35.87%
3 Year Return97.83%
3 Month Return11.08%
1 Year Return3.15%
5 Year Return181.66%

Syncom Formulations (India) Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research